Biohaven (BHVN) News Today $41.44 +2.97 (+7.72%) (As of 12/16/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Biohaven (NYSE:BHVN) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $59.00 target price on shares of Biohaven in a report on Tuesday.December 17 at 8:20 AM | marketbeat.comIs Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17 at 6:59 AM | insidermonkey.comBiohaven Announces Several Clinical And Regulatory MilestonesDecember 16 at 1:42 PM | markets.businessinsider.comBiohaven (NYSE:BHVN) Shares Gap Down - What's Next?Biohaven (NYSE:BHVN) Shares Gap Down - Should You Sell?December 16 at 12:56 PM | marketbeat.comBiohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program UpdatesDecember 16 at 7:30 AM | prnewswire.comBarclays PLC Grows Position in Biohaven Ltd. (NYSE:BHVN)Barclays PLC increased its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 87.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 268,077 shares of the company's stock after buying an additionalDecember 16 at 4:22 AM | marketbeat.comWellington Management Group LLP Purchases 208,472 Shares of Biohaven Ltd. (NYSE:BHVN)Wellington Management Group LLP increased its position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 600.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 243,167 shares of the company's stock after buyingDecember 15 at 4:02 AM | marketbeat.comState Street Corp Sells 393,278 Shares of Biohaven Ltd. (NYSE:BHVN)State Street Corp cut its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 10.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,256,636 shares of the company's stock after selling 393,278 shares during thDecember 14 at 4:08 AM | marketbeat.comBiohaven Ltd. (BHVN) Stock Dips Amidst Industry VolatilityDecember 13, 2024 | gurufocus.comY Intercept Hong Kong Ltd Makes New $1.34 Million Investment in Biohaven Ltd. (NYSE:BHVN)Y Intercept Hong Kong Ltd purchased a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 26,789 shares of the company's stock, valuedDecember 12, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Shares Purchased by XTX Topco LtdXTX Topco Ltd boosted its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 278.5% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 32,510 shares of the company's stock after purchasing an additional 23,921 shares during the period. XTX Topco Ltd's holdings inDecember 8, 2024 | marketbeat.comBiohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual MeetingDecember 6, 2024 | prnewswire.comFmr LLC Sells 13,092 Shares of Biohaven Ltd. (NYSE:BHVN)Fmr LLC trimmed its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 0.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,841,095 shares of the company's stock after selling 13,092 shares during the period. FmrDecember 6, 2024 | marketbeat.comStifel Financial Corp Has $325.27 Million Stock Holdings in Biohaven Ltd. (NYSE:BHVN)Stifel Financial Corp raised its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 0.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 6,509,261 shares of the company's stock after purchasing an additional 28,684 shares during the period. Stifel FinaDecember 5, 2024 | marketbeat.comRedmile Group LLC Has $51.68 Million Holdings in Biohaven Ltd. (NYSE:BHVN)Redmile Group LLC decreased its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,034,219 shares of the company's stock after selling 53,357 shares during the quartDecember 5, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Shares Bought by Point72 Asset Management L.P.Point72 Asset Management L.P. raised its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 745.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,500,284 shares of the company's stock after puDecember 5, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 431,954 Shares of Biohaven Ltd. (NYSE:BHVN)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 563.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 508,622 shDecember 5, 2024 | marketbeat.comKoersdoel Biohaven-aandelen verhoogd, rating gehandhaafd vanwege FDA-katalysatorpotentieelDecember 4, 2024 | nl.investing.comBiohaven Ltd. (NYSE:BHVN) Position Increased by Janus Henderson Group PLCJanus Henderson Group PLC raised its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 5.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,226,393 shares of the company's stock after purchDecember 4, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Position in Biohaven Ltd. (NYSE:BHVN)Charles Schwab Investment Management Inc. grew its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 5.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 632,690 shares of the company's stock after purchasing aDecember 4, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Stock Holdings Decreased by Holocene Advisors LPHolocene Advisors LP decreased its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 49.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 852,627 shares of the company's stock after selling 843,728 shares during the period. Holocene AdvDecember 3, 2024 | marketbeat.comErste Asset Management GmbH Takes Position in Biohaven Ltd. (NYSE:BHVN)Erste Asset Management GmbH purchased a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 51,300 shares of the company's stock,December 3, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Shares Acquired by Fred Alger Management LLCFred Alger Management LLC lifted its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 44.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 58,142 shares of the company's stock after acquiring an additional 17,848 shares during the quarter.December 2, 2024 | marketbeat.comD.A. Davidson & CO. Makes New $1.20 Million Investment in Biohaven Ltd. (NYSE:BHVN)D.A. Davidson & CO. acquired a new stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 23,916 shares of the company's stock, valued at approximateDecember 2, 2024 | marketbeat.comCitigroup Inc. Has $5.99 Million Position in Biohaven Ltd. (NYSE:BHVN)Citigroup Inc. raised its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 125.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,905 shares of the company's stoDecember 2, 2024 | marketbeat.com11,307 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Intech Investment Management LLCIntech Investment Management LLC acquired a new stake in Biohaven Ltd. (NYSE:BHVN - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 11,307 shares of the company's stock, valued at approximDecember 2, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of "Buy" from AnalystsShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the fourteen brokerages that are covering the firm, Marketbeat reports. Thirteen investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy rDecember 2, 2024 | marketbeat.comEventide Asset Management LLC Sells 234,837 Shares of Biohaven Ltd. (NYSE:BHVN)Eventide Asset Management LLC lowered its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 37.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 399,827 shares of the company's stock aNovember 29, 2024 | marketbeat.comBiohaven's Revenue Path: SCA And Obesity TherapiesNovember 29, 2024 | seekingalpha.comBiohaven Ltd. (NYSE:BHVN) Shares Bought by Algert Global LLCAlgert Global LLC grew its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 337.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,392 shares of the company's stock after acquiriNovember 28, 2024 | marketbeat.comPromising Future for Biohaven Ltd.: Buy Rating Affirmed on Pipeline Potential and Strategic AdvancementsNovember 28, 2024 | markets.businessinsider.comBiohaven Ltd.: Buy Rating Affirmed Amid Promising Drug Prospects and Strategic FDA EngagementNovember 27, 2024 | markets.businessinsider.comPromising Potential of Biohaven’s Taldefgrobep Alfa in Obesity Treatment and Niche SMA Market Justifies Buy RatingNovember 26, 2024 | markets.businessinsider.comBiohaven's (BHVN) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and set a $59.00 price target on shares of Biohaven in a research report on Tuesday.November 26, 2024 | marketbeat.comBiohaven’s SMA Trial Miss Bolsters Scholar Rock Stock: Analysts Give Verdicts, Retail Watches CloselyNovember 25, 2024 | msn.comCassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market SessionNovember 25, 2024 | benzinga.comBiohaven's spinal muscular atrophy drug fails to meet main goal in studyNovember 25, 2024 | reuters.comBiohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and ObesityNovember 25, 2024 | prnewswire.comGSA Capital Partners LLP Has $230,000 Stake in Biohaven Ltd. (NYSE:BHVN)GSA Capital Partners LLP cut its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 70.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,609 shares of the company's stock after selling 11,124 shares during theNovember 25, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Shares Sold by First Turn Management LLCFirst Turn Management LLC decreased its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 13.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 315,816 shares of the company's stock after sellingNovember 19, 2024 | marketbeat.comVictory Capital Management Inc. Has $18.17 Million Holdings in Biohaven Ltd. (NYSE:BHVN)Victory Capital Management Inc. boosted its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 67.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 363,615 shares of the company's stock aNovember 19, 2024 | marketbeat.comBiotech-stock investing has one tough test for success — and it’s about to get easierNovember 18, 2024 | msn.comBiohaven stock target cut by analyst on model updatesNovember 15, 2024 | uk.investing.comBiohaven Ltd. (BHVN) Receives a Buy from Morgan StanleyNovember 15, 2024 | markets.businessinsider.comBiohaven (NYSE:BHVN) Shares Down 8% - Here's What HappenedBiohaven (NYSE:BHVN) Stock Price Down 8% - Here's WhyNovember 15, 2024 | marketbeat.comAandelen Biohaven stijgen na verhoging koersdoel door TD Cowen naar $75November 14, 2024 | nl.investing.comBiohaven Ltd.: Promising Prospects and Financial Stability Drive Buy RatingNovember 14, 2024 | markets.businessinsider.comBiohaven Ltd.: Strong Buy Rating Driven by Promising Pipeline Progress and Strategic ResubmissionsNovember 14, 2024 | markets.businessinsider.comRoyal Bank of Canada Lowers Biohaven (NYSE:BHVN) Price Target to $66.00Royal Bank of Canada lowered their target price on shares of Biohaven from $68.00 to $66.00 and set an "outperform" rating on the stock in a report on Wednesday.November 13, 2024 | marketbeat.comBiohaven Ltd.: Biohaven Reports Third Quarter 2024 Financial Results and Recent Business DevelopmentsNovember 13, 2024 | finanznachrichten.de Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket. Click here and I’ll tell you everything you need to know. BHVN Media Mentions By Week BHVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼1.020.80▲Average Medical News Sentiment BHVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼86▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Moderna News Viatris News Summit Therapeutics News Genmab A/S News Dr. Reddy's Laboratories News Sarepta Therapeutics News Catalent News Vaxcyte News Qiagen News Intra-Cellular Therapies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHVN Stock Alerts